-
Document de presse | 2022.03.14
Discovery of an immune escape mechanism promoting Listeria infection of the central nervous system
Some "hypervirulent" strains of Listeria monocytogenes have a greater capacity to infect the central nervous system. Scientists from the Institut Pasteur, Université Paris Cité, Inserm and the Paris Public Hospital Network (AP-HP) have discovered a mechanism that enables cells infected with Listeria monocytogenes to escape immune responses. This mechanism provides infected cells circulating in...
-
Document de presse | 2022.05.23
Stromal cells, maestros of the intestine
The intestine is responsible for absorbing nutrients while protecting the body from external aggression, a task performed by a complex intestinal barrier. Scientists from the Institut Pasteur demonstrated in a mouse model that a population of tissue-resident cells known as stromal cells is crucial for the development of a functional intestinal barrier in the first few weeks after birth. Absence...
-
News | 2022.08.24
ILC3s: "gatekeeper" cells for intestinal immunity
The intestinal mucosa is a key site for interaction and exchange with the external environment. It is therefore under constant surveillance from the immune system. Using an animal model, scientists from the Institut Pasteur and Inserm discovered how a set of cells involved in innate immunity – group 3 innate lymphoid cells – help monitor and maintain this barrier.Our digestive tract contains...
-
News | 2023.06.21
Malaria: parasite migration strategy revealed
Malaria is a disease transmitted by mosquitoes that are vectors of parasites in the genus Plasmodium. Scientists from the Institut Pasteur, in collaboration with specialized physicists in Brazil and Germany, have elucidated the search strategy used by parasites to reach the bloodstream.
-
News | 2023.11.23
The 40-year fight against HIV: we speak to Marc Dixneuf, CEO of AIDES
In 1983 the AIDS virus, HIV, was isolated by virologists at the Institut Pasteur. Forty years later, HIV-positive patients can live with the virus if they are diagnosed in time and receive the right treatment. Treatments are constantly being improved – great strides are being made as a result of close cooperation between patients, caregivers and scientists. They are the bedrock of the 40-year...
-
News | 2023.11.14
Discovery of peritumoral stromal cells that regulate antitumor immunity
A team from the Institut Pasteur has discovered a new population of cells that develops around a tumor mass. This discovery opens up a new avenue of treatment for solid tumors. This offers hope for improving the treatment of cancers for which immunotherapies are often ineffective, such as pancreatic, breast and prostate cancer.
-
News | 2023.12.20
Hepatitis B: using mathematics to reveal the best treatment model in The Gambia
To accelerate momentum in the global fight against hepatitis B, expanding testing and treatment services in resource-limited countries is crucial, especially in sub-Saharan Africa. But determining which patients are eligible for treatment is a complex process and requires tests that are not widely accessible in these regions. Should all people infected with the virus be treated without assessing...
-
News | 2024.06.11
Strengthening Multisectoral and Regional Cooperation to Mitigate Vector-Borne Diseases in the Mediterranean
The interconnectedness of our world has brought about significant challenges in public health, particularly with the rise of infectious epidemics. Globalization, climate change, and rapid urbanization have created fertile ground for the emergence and spread of diseases, as starkly illustrated by the COVID-19 pandemic. Among these threats, vector-borne diseases transmitted by mosquitoes and ticks...
-
Fiche maladie | 2015.10.06
Leptospirosis
Leptospirosis is a bacterial disease that occurs worldwide. It is transmitted from animals to humans via urine. The main animal reservoirs are rats, but any mammals can carry the bacteria. In humans, leptospirosis is often mild, but it can lead to kidney failure or even death in 5 to 20% of cases.
-
News | 2023.05.23
Creation of an European Biocluster for Emerging Infectious Diseases
The project "Infectious Diseases Cluster" (IDCluster) has been selected for the Healthcare Innovation 2030 plan. This strategy aims to strengthen biomedical research in France. Coordinated by Lyonbiopôle and supported by the Auvergne-Rhône-Alpes region, this European-scale cluster aims to accelerate progress in the field of emerging diseases, by working with the Institut Pasteur among others.